Garth Nicholas

Garth Nicholas

UNVERIFIED PROFILE

Are you Garth Nicholas?   Register this Author

Register author
Garth Nicholas

Garth Nicholas

Publications by authors named "Garth Nicholas"

Are you Garth Nicholas?   Register this Author

34Publications

1282Reads

48Profile Views

Inpatients versus outpatients with advanced non-small cell lung cancer: Characteristics and outcomes.

Cancer Treat Res Commun 2019 23;19:100130. Epub 2019 Mar 23.

Department of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada; Ottawa Hospital Cancer Centre, Ottawa, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada; Ottawa Hospital Research Institute, 725 Parkdale Avenue, Ottawa, Ontario K1Y4E9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2019.100130DOI Listing
September 2019

A prospective intervention to improve happiness and reduce burnout in oncologists.

Support Care Cancer 2019 Apr 30;27(4):1563-1572. Epub 2018 Nov 30.

Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4567-5DOI Listing
April 2019

The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 01 8;19(1):e91-e99. Epub 2017 Jun 8.

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.05.018DOI Listing
January 2018

Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors.

Case Rep Oncol 2017 May-Aug;10(2):462-472. Epub 2017 May 23.

Ottawa Hospital Research Institute, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475806DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471759PMC
May 2017

Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.

Lung Cancer 2016 07 14;97:15-21. Epub 2016 Apr 14.

Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.04.007DOI Listing
July 2016

Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours.

PLoS One 2015 7;10(4):e0123890. Epub 2015 Apr 7.

Division of Laboratory Medicine, Department of Anatomical Pathology, Ottawa, Ontario, Canada; University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123890PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388816PMC
April 2016

Inhibition of glioblastoma malignancy by Lgl1.

Oncotarget 2014 Nov;5(22):11541-51

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6, Canada. Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada. Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294391PMC
http://dx.doi.org/10.18632/oncotarget.2580DOI Listing
November 2014

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

J Thorac Oncol 2014 Oct;9(10):1449-58

*The Canadian Centre for Applied Research in Cancer Control, and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; †The British Columbia Cancer Agency, Vancouver, British Columbia, Canada; ‡Brock University, St. Catherines, Ontario, Canada; §Cancer Care Ontario and the Juravinski Cancer Centre, Hamilton, Ontario, Canada; ‖University Health Network and Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ¶The Canadian Centre for Applied Research in Cancer Control, the British Columbia Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; #The University of British Columbia School of Population and Public Health, Vancouver, British Columbia, Canada; **Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; ††The British Columbia Cancer Agency and The Canadian Centre for Applied Research in Cancer Control and the University of British Columbia, Vancouver, British Columbia, Canada; ‡‡Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, Nova Scotia, Canada; §§The Vancouver General Hospital, Vancouver, British Columbia, Canada; ‖‖Fionna Stanley Hospital and Sir Charles Gairdner Hospital, Perth, Western Australia; ¶¶Université Laval, Québec, Canada; ##Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; ***The Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada; †††Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ‡‡‡University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada; §§§Foothills Medical Centre, Calgary, Alberta, Canada; ‖‖‖Memorial University, St. Johns, Newfoundland, Canada; ¶¶¶The Ottawa Hospital, Ottawa, Ontario, Canada; ###Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ****The Vancouver General Hospital and The University of British Columbia, Vancouver, British

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165479PMC
October 2014

A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.

J Neurooncol 2012 Apr 3;107(2):343-9. Epub 2011 Nov 3.

Princess Margaret Hospital, 610 University Avenue, Suite 18-717, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0747-6DOI Listing
April 2012

Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer.

J Thorac Oncol 2008 Feb;3(2):163-9

Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318160c0cbDOI Listing
February 2008

A population-based analysis of second primary cancers after irradiation for rectal cancer.

Am J Clin Oncol 2007 Aug;30(4):333-9

Division of Radiation Oncology, Ottawa Hospital Regional Cancer Center, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000258084.55036.9eDOI Listing
August 2007

Second primary cancers after prostatic irradiation: ensuring an appropriate analysis.

Cancer 2007 Jan;109(1):164; author reply 165

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22377DOI Listing
January 2007

Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer.

Int J Radiat Oncol Biol Phys 2006 Jul 20;65(3):661-8. Epub 2006 Mar 20.

Division of Radiation Oncology, The Ottawa Hospital Regional Cancer Center, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160502961
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2005.11.013DOI Listing
July 2006

Association between anemia arising during therapy and outcomes of chemoradiation for limited small-cell lung cancer.

J Thorac Oncol 2006 Feb;1(2):146-51

Division of Medical Oncology, The Ottawa Hospital Regional Cancer Centre and the University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2006